Neogen (NEOG) EBIT (2016 - 2025)
Historic EBIT for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to -$5.4 million.
- Neogen's EBIT rose 9882.47% to -$5.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$627.2 million, marking a year-over-year decrease of 4581.37%. This contributed to the annual value of -$1.1 billion for FY2025, which is 190863.07% down from last year.
- As of Q4 2025, Neogen's EBIT stood at -$5.4 million, which was up 9882.47% from -$16.1 million recorded in Q3 2025.
- Neogen's EBIT's 5-year high stood at $23.4 million during Q2 2023, with a 5-year trough of -$611.2 million in Q2 2025.
- Over the past 5 years, Neogen's median EBIT value was $12.2 million (recorded in 2021), while the average stood at -$44.6 million.
- As far as peak fluctuations go, Neogen's EBIT surged by 28893.68% in 2023, and later plummeted by 478700.15% in 2025.
- Over the past 5 years, Neogen's EBIT (Quarter) stood at $12.5 million in 2021, then plummeted by 161.4% to -$7.7 million in 2022, then surged by 288.94% to $14.5 million in 2023, then tumbled by 3262.7% to -$457.5 million in 2024, then soared by 98.82% to -$5.4 million in 2025.
- Its EBIT was -$5.4 million in Q4 2025, compared to -$16.1 million in Q3 2025 and -$611.2 million in Q2 2025.